Windlas Biotech appoints Komal Gupta as CEO
The company is in the process of appointing the new Chief Financial Officer shortly and in the interim, Komal Gupta will continue as CFO
The company is in the process of appointing the new Chief Financial Officer shortly and in the interim, Komal Gupta will continue as CFO
It will enable the company to branch out to new geographies and strengthen its presence in South Africa
He has over 22 years of experience in pharmaceutical sales & business development
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech
Subscribe To Our Newsletter & Stay Updated